Nu Skin Enterprises, Inc. (NUS) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

+473.3%

$27.55

vs $4.81 price

Levered DCF

$12.95

After debt service

Piotroski score

4 / 9

Average

Altman Z-score

3.7

Safe zone

Rating

Overall 3 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
P/E	2.96×	-2.34×	114.24×	20.08×	17.32×	14.93×	13.09×	27.75×
P/B	0.59×	0.53×	1.17×	2.35×	2.79×	3.19×	2.6×	4.33×
P/S	0.32×	0.2×	0.49×	0.95×	0.94×	1.11×	0.94×	1.26×
EV / EBITDA	2.29×	-8.04×	6.43×	13.51×	8.48×	8.91×	7.11×	8.69×
Gross margin	69.4%	68.2%	68.9%	71.7%	75.0%	74.5%	76.0%	76.3%
Operating margin	6.1%	-8.8%	2.5%	5.0%	8.7%	10.0%	11.0%	9.0%
Net margin	10.8%	-8.5%	0.4%	4.7%	5.5%	7.4%	7.2%	4.5%
Current ratio	2.08×	1.82×	2.13×	2.12×	1.65×	1.66×	2.07×	1.82×
Debt / equity	0.45×	0.73×	0.74×	0.58×	0.55×	0.56×	0.58×	0.55×
Interest coverage	6.52×	-5.74×	1.89×	5.07×	21.27×	19.66×	13.93×	0×
Dividend yield	2.5%	3.5%	8.0%	3.7%	3.0%	2.7%	3.6%	2.4%
Payout ratio	7.4%	-8.1%	903.1%	73.5%	51.8%	41.0%	47.4%	66.1%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Return on equity	19.9%	-22.5%	1.0%	11.7%	16.1%	21.4%	19.8%	15.6%
Return on invested capital	6.3%	-10.4%	1.0%	7.3%	9.8%	12.9%	12.3%	10.1%
Return on assets	11.4%	-10.0%	0.5%	5.8%	7.7%	9.8%	9.8%	7.2%
Free cash flow yield	9.7%	20.5%	6.2%	2.3%	2.9%	11.0%	4.9%	3.9%
Earnings yield	33.8%	-42.8%	0.9%	5.0%	5.8%	6.7%	7.6%	3.6%
Enterprise value	$599.8M	$633.5M	$1.3B	$2.4B	$2.7B	$3B	$2.4B	$3.4B
Net debt / EBITDA	0.48×	-3.7×	1.72×	1.46×	0.51×	0.29×	0.5×	0.11×
Cash conversion cycle (days)	132	114	155	177	195	147	156	150